Chapter 008

Cholinergic Drugs

Frank J. Dowd

CITED REFERENCES

  1. Al-Hashimi I: Xerostomia secondary to Sjögren’s syndrome in the elderly: recognition and management. Drugs Aging 22:887-899, 2005. PUBMED Abstract
  2. Ammirati JF, Traquair JA, Horgen PA: Poisonous mushrooms of the northern United States and Canada, Minneapolis, 1986, University of Minnesota Press.
  3. Beers WH, Reich E: Structure and activity of acetylcholine. Nature 228:917-922, 1970. PUBMED Abstract
  4. Birks J: Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev Issue 1:CD005593, 2006. PUBMED Abstract
  5. Burns A, O’Brien J: Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol 20:732-755, 2006. PUBMED Abstract
  6. Cannard K: The acute treatment of nerve agent exposure. J Neurol Sci 249:86-94, 2006. PUBMED Abstract
  7. Cummings JL: Alzheimer’s disease. N Engl J Med 351:56-67, 2004. PUBMED Abstract
  8. Dale HH: The action of certain esters and ethers of choline, and their relation to muscarine. J Pharmacol Exp Ther 6:147-190, 1914.
  9. Dowd FJ: Saliva and dental caries. Dent Clin North Am 43:579-597, 1999. PUBMED Abstract
  10. Engelhardt E, Loewi O: Fermentative Azetylcholinspaltung im Blut und ihre Hemmung durch Physostigmine. Naunyn Schmiedebergs Arch Pharmacol 150:1-13, 1930.
  11. Featherstone JD: Science and practice of caries prevention. J Am Dent Assoc 131:887-899, 2000. PUBMED Abstract
  12. Fox PC: Salivary enhancement therapies. Caries Res 38:241-246, 2004. PUBMED Abstract
  13. Furchgott RF: Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci Rep 19:235-251, 1999. PUBMED Abstract
  14. Giacobini E: Cholinesterase inhibitors: from the Calabar bean to Alzheimer’s therapy. In Giacobini E, editor: Cholinesterases and cholinesterase inhibitors, London, 2000, Martin Dubitz.
  15. Harkany T, Penke B, Luiten PG: β-Amyloid excitotoxicity in rat magnocellular nucleus basalis: effect of cortical deafferentation of cerebral blood flow regulation and implications for Alzheimer’s disease. Ann N Y Acad Sci 903:374-386, 2000.
  16. Hunt R, Taveau RM: On the physiological action of certain choline derivatives and new methods for detecting choline. BMJ 2:1788-1791, 1906.
  17. Ignarro LJ, Cirino G, Casini A, et al: Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 34:879-886, 1999. PUBMED Abstract
  18. Lange W, von Krueger G: Über Ester der Monofluorphosphorsäure. Bericht Deutschen Keramischen Gesellschaft 65:598-1601, 1932.
  19. Mandel ID: The role of saliva in maintaining oral homeostasis. J Am Dent Assoc 119:298-304, 1989. PUBMED Abstract
  20. Mandel ID, Wotman S: The salivary secretions in health and disease. Oral Sci Rev 8:25-47, 1976. PUBMED Abstract
  21. Marquis RE, Whitson JT: Management of glaucoma: focus on pharmacological therapy. Drugs Aging 22:1-21, 2005. PUBMED Abstract
  22. Massoulié J, Bon S: The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Annu Rev Neurosci 5:57-106, 1982. PUBMED Abstract
  23. Remen L: Zur Pathogenese und Therapie der Myasthenia gravis pseudoparalytic. Deutsche Z Nervenheilkunde 128:66-78, 1932.
  24. Schwendimann RN, Burton E, Minagar A: Management of myasthenia gravis. Am J Ther 12:262-268, 2005. PUBMED Abstract
  25. Senanayake N, Karalliedde L: Neurotoxic effects of organophosphorus insecticides: an intermediate syndrome. N Engl J Med 316:761-763, 1987. PUBMED Abstract
  26. Sussman JL, Harel M, Frolow F, et al: Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253:872-879, 1991. PUBMED Abstract
  27. Walker MB: Case showing the effect of prostigmine on myasthenia gravis. Proc R Soc Lond [Biol] 28:759-761, 1935. PUBMED Abstract

GENERAL REFERENCES

  1. Allingham RR, Shields MB: Shields’ textbook of glaucoma, ed 5, Philadelphia, 2005, Lippincott Williams & Wilkins.
  2. Birdsall NJM, Brown DA, Buckley NJ, et al: Acetylcholine receptors (muscarinic). In The IUPHAR receptor database online, 2005, IUPHAR Media. Available at: http://www.iuphar-db.org/GPCR/ReceptorListForward. Accessed September 28, 2009.
  3. Massoulie J: Molecular forms and anchoring of acetylcholinesterase. In Giacobini E, editor: Cholinesterase and cholinesterase inhibitors, London, 2000, Martin Dunitz.
  4. Silman I: Cholinergic mechanisms: function and dysfunction, New York, 2004, Taylor & Francis.Foot note for box